Neuraura was founded to improve the lives of billions of people suffering from neurological, psychiatric and sensory conditions through the development of fully implantable medical devices with closed-loop recording and stimulation, also known as neuromodulation.
Neuromodulation and brain machine interfaces (“BMI”) are two of the fastest growing fields in Medical Technology. Applications for neuromodulation include neurological, psychiatric and sensory conditions, including “below the neck” applications. Applications for BMI span communications, prosthetic control and cognitive enhancement.
Neuraura’s initial clinical application is for the epilepsy surgery and monitoring market, which represents an under-served market opportunity, has an accelerated regulatory pathway and provides access to electrophysiological patient data. The components of Neuraura’s solution include proprietary microsensors, hardware to wirelessly transmit data and software to visualize the data. The company will also commercialize its technology for non-clinical (research and drug-screening) applications.